Teva gets FDA nod for breast cancer treatment
The pharmaceutical company reported the commercial launch of generic Arimidex.
Based on IMS sales data, the branded drug has annual sales of about $916.8 million.
Teva said that it began its commercial launch of Anastrozole tablets 1 mg, the company’s generic version of AstraZeneca’s Arimidex. The product is used to treat certain forms of breast cancer in postmenopausal women.
Published by Globes [online], Israel business news - www.globes-online.com - on June 29, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options